Sign In
Buy VTVT
$32.35
-0.330 (-1.01%)
At Close: Jul 31, 2026
vTv Therapeutics Announces Publication in Diabetes Care of Results from SimpliciT-1 Study of TTP399 in Patients with Type 1 Diabetes
10:30am, Tuesday, 23'rd Feb 2021
Results found a clinically meaningful decrease in frequency of severe and symptomatic hypoglycemia in addition to statistically significant reductions in HbA1c Results found a clinically meaningful de
vTv Therapeutics Announces Initiation of Multiple Ascending Dose Study of HPP737, an Oral PDE4 Inhibitor for the Treatment of Psoriasis
04:05pm, Wednesday, 17'th Feb 2021
Phase 1 multiple ascending dose study to evaluate safety of HPP737 in healthy volunteers and inform dose selection for phase 2 planned for 2H 2021
VTVT Stock Price Increases Over 30% Pre-Market: Why It Happened
04:47am, Thursday, 04'th Feb 2021
The stock price of vTv Therapeutics Inc (NASDAQ: VTVT) is trading at over 30% as of 4:38 AM ET today. This is why it happened.
vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually
04:30pm, Wednesday, 06'th Jan 2021
HIGH POINT, N.C., Jan. 06, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for t
HIGH POINT, N.C., Dec. 15, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) today announced that the Phase 2 Elevage study of azeliragon in people with mild Alzheimer's disease and type
vTv Therapeutics Announces Licensing Agreement for Novel Nrf2 Activator to Anteris Bio
07:30am, Tuesday, 15'th Dec 2020
HIGH POINT, N.C., Dec. 15, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq:VTVT) today announced that vTv Therapeutics LLC (“vTv”) has entered into a licensing agreement with Anteris Bio fo
Why 3 Health Care Stocks Are Moving: Tv Therapeutics, Solid Biosciences, Sellas Life Sciences
12:33pm, Friday, 11'th Dec 2020
Tv Therapeutics (NASDAQ: VTVT) shares were trading higher on Friday after the company said its Phase 2 Simplici-T1 study of TTP399 achieved the primary objective of a statistically significant reduc
VTVT Stock: Why vTv Therapeutics Is Soaring on Friday
11:06am, Friday, 11'th Dec 2020
Shares of VTVT stock are taking off on Friday after vTv Therapeutics' parent company purchased 625,000 shares for $1.60 per share. The post VTVT Stock: Why vTv Therapeutics Is Soaring on Friday appear
Where Do Hedge Funds Stand On vTv Therapeutics Inc (VTVT)?
08:51pm, Saturday, 28'th Nov 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of the more than 81
7 Biotech Penny Stocks Worth a Gamble
11:50am, Wednesday, 11'th Nov 2020
With the pandemic drawing much attention toward biotech stocks, there are some interesting ideas among in the small-cap field, but only if you understand the severe risks involved. The post 7 Biotech
vTv Therapeutics Announces 2020 Third Quarter Financial Results and Update
04:30pm, Thursday, 05'th Nov 2020
HIGH POINT, N.C., Nov. 05, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the third quarter ended September 30, 2020, and provided an update on the p
HIGH POINT, N.C., Nov. 04, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) today reported baseline characteristics for the enrolled subjects in the ongoing Elevage clinical study of aze
HIGH POINT, N.C., Oct. 29, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) today announced that it will make an oral presentation at the 13th Clinical Trials on Alzheimer's Disease (CTA
